The International Longevity Centre – UK (a think tank, part of the International Longevity Centre Global Alliance) have produced an economic analysis of the English flu vaccination programme. The report presents findings from a new economic model of the costs and benefits from flu vaccination in England using recent efficacy data. It introduces a conservative, static model which provides a partial cost-benefit analysis of vaccination under various scenarios. Amongst the findings it is reported that the flu vaccination averts between 180,000 and 626,000 cases of influenza per year in England and costs £50,610 per death averted.
The Health and Sport Committee of the Scottish Parliament have published the official report of their meeting on 27 March 2018 on neurological conditions. The meeting was part of the committee inquiry into the preventative agenda. Part of the discussion focused on the need for economic evaluation of services and highlighted work that the Sue Ryder charity had undertaken with the New Economics Foundation to develop a model of neurological care.
The Scottish Government have published the ‘Scottish strategy for autism and priorities 2018-2021‘. The document sets out the priorities for action through to 2021 to improve outcomes for autistic people living in Scotland. They have also published research which informed the development of the strategy.
The ‘Scottish strategy for autism engagement analysis‘ provides analysis of the Scottish strategy for autism’s engagement exercise to gather on views on the final phase of the Scottish strategy for autism and the ‘Microsegmentation of the autism spectrum‘ report provides economic research on autism and implications for Scotland. The report has information on prevalence, costs, economic impact and segmentation of the autism spectrum.
The National Institute for Health and Care Excellence (NICE) have published draft guidance for consultation on decision making and mental capacity. The guidance aims to help health and social care practitioners support people to make their own decisions where they have the capacity to do so, and to help practitioners to keep people who lack capacity at the centre of the decision-making process. The consultation on the guideline, and economic model, is open to 5 February 2018.
The Centre for Health Economics (CHE) at the University of York have published a scoping review on social care economic evaluation methods. A systematic review of the published literature and a survey of experts were undertaken to inform NICE on the methods available for use in undertaking economic evaluation of social care interventions, and the methods in development, the challenges faced and the methods gaps.
The PharmacoEconomics journal has a supplement issue on estimating utility values for economic evaluation. The supplement is volume 35, issue 1 supplement, December 2017. The full list of articles is listed below, the journal is available in full text but may require a login off-campus.
Editorial: Heath State Utility Values for Cost-Effectiveness Models / Jonathan Karnon
Editorial: Special Edition on Utility Measurement, PharmacoEconomics / Andrew Lloyd
Commentary: Sourcing and Using Appropriate Health State Utility Values in Economic Models in Health Care / Roberta Ara, Tessa Peasgood, Clara Mukuria, Helene Chevrou-Severac…
International Regulations and Recommendations for Utility Data for Health Technology Assessment / Donna Rowen, Ismail Azzabi Zouraq, Helene Chevrou-Severac…
A Review of Generic Preference-Based Measures for Use in Cost-Effectiveness Models / John Brazier, Roberta Ara, Donna Rowen, Helene Chevrou-Severac
The Role of Condition-Specific Preference-Based Measures in Health Technology Assessment / Donna Rowen, John Brazier, Roberta Ara, Ismail Azzabi Zouraq
The Identification, Review and Synthesis of Health State Utility Values from the Literature / Roberta Ara, John Brazier, Tessa Peasgood, Suzy Paisley
The Use of Mapping to Estimate Health State Utility Values / Roberta Ara, Donna Rowen, Clara Mukuria
Recommended Methods for the Collection of Health State Utility Value Evidence in Clinical Studies / Roberta Ara, John Brazier, Tracey Young
The Use of Health State Utility Values in Decision Models / Roberta Ara, John Brazier, Ismail Azzabi Zouraq
Estimating Health State Utility Values for Comorbidities / Roberta Ara, John Brazier
A report by HERU authors has been published by Food Standards Scotland. The report provides a review of the evidence base for modelling the costs of overweight, obesity and diet-related illness for Scotland, and critical appraisal of the cost-effectiveness evidence base for population wide interventions to reduce overweight, obesity and diet-related illness.
McNamee, P., Neilson, A., Norwood, P., Avenell, A. and Ludbrook, A. (2017) ‘A review of the evidence base for modelling the costs of overweight, obesity and diet-related illness for Scotland, and critical appraisal of the cost-effectiveness evidence base for population wide interventions to reduce overweight, obesity and diet-related illness’, Aberdeen: Food Standards Scotland.